Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Dermatology

Understanding Lichen Planopilaris: An Orientation

At a Glance

Lichen planopilaris is a rare condition in which the immune system attacks hair follicles and can permanently scar them. Treatment mainly aims to calm inflammation, relieve itching or burning, and stop further loss rather than regrow hair from destroyed follicles.

A diagnosis of Lichen Planopilaris (LPP) can feel overwhelming, especially because it is a condition many people—and even some doctors—have never heard of. You are likely here because you have noticed patches of hair loss, perhaps accompanied by itching or burning, and have been told that this is an “immune-mediated scarring alopecia.”

In plain language, this means your immune system is mistakenly targeting your hair follicles, leading to permanent hair loss in the affected areas. While this is a rare condition, understanding how it works is the first step in taking control of your care.

What This Means For You Now

  • It is not contagious: You cannot pass it to anyone else.
  • It is not caused by poor hygiene: How you wash your hair did not cause this.
  • It is not your fault: LPP is an immune-mediated disease, not the result of something you did wrong.
  • The course is variable: Some people experience a single episode that eventually stops, while others have a chronic, slowly progressing course.

Why the Hair Loss is Permanent

To understand LPP, it helps to think of the hair follicle as having a “command center” called the bulge. This area contains stem cells, which are responsible for regenerating the hair follicle and growing new hair [1].

In LPP, immune cells—specifically T cells and macrophages—gather around the upper follicle and target this command center [2][3]. This response causes two major problems:

  1. Destruction of Stem Cells: The immune system may trigger a process called epithelial–mesenchymal transition (EMT), which research suggests alters the stem cells’ identity, making them unable to grow hair [4][1].
  2. Scarring (Fibrosis): As the follicle is destroyed, the body replaces the delicate hair-producing structure with fibrosis, or scar tissue [5].

Once a follicle has been completely replaced by scar tissue, it can no longer produce a hair. This is why LPP is classified as a cicatricial (scarring) alopecia. Note that permanence applies to follicles that have actually been destroyed and scarred; partially injured follicles may sometimes recover when inflammation is controlled.

Three Ways LPP Can Appear

LPP is actually a “spectrum” of disease. Doctors generally recognize three main ways it shows up, though the underlying immune response is thought to be similar in all of them [6].

1. Classic Lichen Planopilaris

This is the most common form. It typically appears as patchy areas of hair loss, often starting at the top (vertex) of the head [7]. You might see redness (erythema) or small scales and “casts” wrapped around the base of individual hairs [8]. It often causes physical symptoms like itching or a burning sensation.

2. Frontal Fibrosing Alopecia (FFA)

FFA is considered a variant of LPP that follows a very specific pattern: a slow, uniform recession of the front and side hairline [9]. It is often accompanied by the thinning or complete loss of eyebrows [10]. While it most commonly affects postmenopausal women, it can occur in anyone.

3. Graham-Little-Piccardi-Lassueur Syndrome (GLPLS)

This is an extremely rare variant. It is defined by a “triad” of three specific symptoms occurring together:

  • Scarring hair loss on the scalp.
  • Loss of hair in the armpits or groin (which is usually non-scarring).
  • Small, rough, “spiny” bumps on the skin of the body, known as follicular papules [11][12].

Understanding the Rarity

If you feel like your local doctor was unfamiliar with LPP, you are likely correct. One clinical study reported the prevalence of LPP to be approximately 13.4 out of every 100,000 adults, though exact numbers vary by region and definition [13]. Because it is so rare, many general practitioners see only one or two cases in their entire career. This rarity highlights why it is important to work with a dermatologist who has specific experience in hair disorders.

Reframing the Goal of Treatment

The most important thing to understand about LPP treatment is what it can—and cannot—do. Because the stem cells are destroyed in scarred areas, treatment usually cannot regrow hair that has already been lost [14][15].

Instead, the primary goals of treatment are:

  • Controlling Inflammation: The main priority is to suppress the immune system to protect healthy follicles [15].
  • Symptom Relief: Reducing the itch, pain, or burning that often accompanies active disease [16].
  • Stabilization: Achieving a state where the hair loss is no longer expanding, even if the existing patches remain [17].

While some patients may see a small amount of regrowth in areas that were only partially damaged (not yet fully scarred), your care team will focus on protecting the hair you still have [18]. Success in LPP treatment is measured by stability, not by a return to your original hair density.

Common questions in this guide

What is lichen planopilaris, and why can it cause permanent hair loss?
Lichen planopilaris (LPP) is an immune-mediated form of scarring hair loss in which immune cells attack the upper part of a hair follicle. If the follicle’s stem-cell area is destroyed and replaced by scar tissue, it can no longer grow hair; partially injured follicles may recover when inflammation is controlled.
Can I catch LPP from someone, or did poor hair hygiene cause it?
No, LPP is not contagious. It is not caused by poor hygiene, hair washing, or anything you did; it reflects an abnormal immune response.
What are the different forms of lichen planopilaris?
LPP is a spectrum that includes classic LPP, frontal fibrosing alopecia (FFA), and the much rarer Graham-Little-Piccardi-Lassueur syndrome. Classic LPP usually causes patchy scalp loss, FFA causes a receding front or side hairline and often eyebrow loss, and GLPLS combines scalp scarring with usually non-scarring underarm or groin hair loss and rough body bumps.
What symptoms may mean my LPP is active?
Active LPP may cause itching, burning, tenderness, redness, scaling, or small hair casts around follicles, along with expanding patches of hair loss. In FFA, a receding hairline or thinning eyebrows can be important clues; a dermatologist can examine the scalp and monitor changes over time.
Can treatment regrow hair lost from LPP?
Treatment usually cannot regrow hair from follicles that have been completely destroyed and replaced by scar tissue. Its main goals are to calm inflammation, relieve symptoms, protect remaining follicles, and stop or slow further hair loss; partially injured follicles may sometimes recover.
How will my doctor know whether LPP is stable?
A dermatologist may use a trichoscope to look for signs of active inflammation and may track symptoms and hair changes over time. A disease activity measure such as the LPP Activity Index can help assess whether the condition is stable or progressing.

Get notified when new evidence is published on Lichen planopilaris.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Frontiers in Lichen Planopilaris and Frontal Fibrosing Alopecia Research: Pathobiology Progress and Translational Horizons.

    Senna MM, Peterson E, Jozic I, et al.

    JID innovations : skin science from molecules to population health 2022; (2(3)):100113 doi:10.1016/j.xjidi.2022.100113.

    PMID: 35521043
  2. 2

    Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia.

    Chen Q, Li Y, Zhu Q, et al.

    Cell & bioscience 2025; (15(1)):102 doi:10.1186/s13578-025-01447-1.

    PMID: 40671126
  3. 3

    Profiling the human hair follicle immune system in lichen planopilaris and frontal fibrosing alopecia: can macrophage polarization differentiate these two conditions microscopically?

    Harries M, Hardman J, Chaudhry I, et al.

    The British journal of dermatology 2020; (183(3)):537-547 doi:10.1111/bjd.18854.

    PMID: 31883384
  4. 4

    Epithelial-to-Mesenchymal Stem Cell Transition in a Human Organ: Lessons from Lichen Planopilaris.

    Imanishi H, Ansell DM, Chéret J, et al.

    The Journal of investigative dermatology 2018; (138(3)):511-519 doi:10.1016/j.jid.2017.09.047.

    PMID: 29106928
  5. 5

    M2 Macrophage and Extracellular Matrix Genes Are Enriched in High-Activity Lichen Planopilaris.

    Yıldız-Altay Ü, Burns LJ, Chen LC, et al.

    Dermatology research and practice 2025; (2025()):5545886 doi:10.1155/drp/5545886.

    PMID: 40475059
  6. 6

    Delphi Consensus on the Distinct Clinical and Histopathological Features of Lichen Planopilaris and Frontal Fibrosing Alopecia: Insights From the Hair Diseases EADV Task Force.

    Starace MVR, Pampaloni F, Iorizzo M, et al.

    International journal of dermatology 2025; (64(7)):1246-1254 doi:10.1111/ijd.17780.

    PMID: 40207851
  7. 7

    Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience.

    Mardones F, Shapiro J

    Clinical and experimental dermatology 2017; (42(7)):755-759 doi:10.1111/ced.13203.

    PMID: 28748570
  8. 8

    Recalcitrant lichen planopilaris and frontal fibrosing alopecia responding to tildrakizumab.

    Trindade de Carvalho L, Meah N, Wall D, Sinclair R

    Dermatologic therapy 2020; (33(4)):e13694 doi:10.1111/dth.13694.

    PMID: 32458516
  9. 9

    Clinical characteristics, trichoscopy, histopathology and treatment outcomes of frontal fibrosing alopecia in an Asian population: A retro-prospective cohort study.

    Panchaprateep R, Ruxrungtham P, Chancheewa B, Asawanonda P

    The Journal of dermatology 2020; (47(11)):1301-1311 doi:10.1111/1346-8138.15517.

    PMID: 32710515
  10. 10

    Frontal fibrosing alopecia.

    Kerkemeyer KLS, Eisman S, Bhoyrul B, et al.

    Clinics in dermatology 2021; (39(2)):183-193 doi:10.1016/j.clindermatol.2020.10.007.

    PMID: 34272007
  11. 11

    Graham-Little Piccardi Lassueur syndrome and review of the literature.

    Alkhayal FA, Alsudairy F, Al Mubarak L, Almohanna HM

    Clinical case reports 2021; (9(9)):e04761 doi:10.1002/ccr3.4761.

    PMID: 34504697
  12. 12

    Graham-Little-Piccardi-Lassueur Syndrome with Mucosal Involvement: A Rare Case.

    Polra RV, Tandel JJ, Nair PA

    International journal of trichology 2023; (15(6)):251-254 doi:10.4103/ijt.ijt_88_22.

    PMID: 39600425
  13. 13

    Prevalence and Treatment Patterns in Patients With Lichen Planopilaris.

    Pelet Del Toro N, Strunk A, Garg A, Han G

    JAMA dermatology 2024; (160(8)):865-868 doi:10.1001/jamadermatol.2024.1445.

    PMID: 38865116
  14. 14

    Hair transplantation for the treatment of lichen planopilaris and frontal fibrosing alopecia: A report of two cases.

    Liu YS, Jee SH, Chan JL

    The Australasian journal of dermatology 2018; (59(2)):e118-e122 doi:10.1111/ajd.12682.

    PMID: 28736812
  15. 15

    Management of classic lichen planopilaris: The EADV task force on hair diseases position statement.

    Seyed Jafari SM, Starace M, Katoulis A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2026; (40(8)):1306-1317 doi:10.1111/jdv.70379.

    PMID: 41848299
  16. 16

    A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris.

    Svigos K, Yin L, Fried L, et al.

    American journal of clinical dermatology 2021; (22(5)):681-692 doi:10.1007/s40257-021-00630-7.

    PMID: 34347282
  17. 17

    Pruritus in Lichen Planopilaris and Frontal Fibrosing Alopecia-Clinical Characteristics and Dermoscopic Correlations.

    Kołcz K, Krawczyk-Wołoszyn K, Reich A, Żychowska M

    Journal of clinical medicine 2024; (13(16)) doi:10.3390/jcm13164898.

    PMID: 39201040
  18. 18

    Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study.

    Jerjen R, Pinczewski J, Sinclair R, Bhoyrul B

    Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(12)):2440-2447 doi:10.1111/jdv.17604.

    PMID: 34415628

This overview of lichen planopilaris is for informational purposes only and does not constitute medical advice. A dermatologist experienced in scarring hair loss can interpret your symptoms and guide your care.